Format

Send to

Choose Destination
Am J Trop Med Hyg. 2009 Nov;81(5):911-6. doi: 10.4269/ajtmh.2009.09-0237.

Immunologic profiles of persons recruited for a randomized, placebo-controlled clinical trial of hookworm infection.

Author information

1
University of Nottingham, United Kingdom. daniel.blount@nottingham.ac.uk

Abstract

Data from epidemiologic studies suggest that hookworm infections, in establishing an immunologic phenotype conducive to parasite survival, may protect against the development of allergic disease. We describe immunologic findings from a clinical study designed to investigate the safety of iatrogenic hookworm infection in participants with allergic rhinitis. The low, relatively safe level of hookworm infection used in this study was immunogenic, inducing eosinophilia and a significant specific IgG response. Importantly, no potentiation of IgE responses to the environmental allergens to which the participants were sensitized was seen. However, no evidence of systemic immune regulation was seen in infected participants. This finding may indicate that the level of infection or the frequency of infection may have to be altered in future trials to induce a therapeutically conducive immunologic phenotype.

PMID:
19861631
DOI:
10.4269/ajtmh.2009.09-0237
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Ingenta plc
Loading ...
Support Center